Artificial intelligence (AI) is not only boosting the business for tech companies. Healthcare and biotech industries are also taking full advantage of AI to redesign the ways in which drugs are discovered and developed. One such AI story belongs to a non-tech company, Recursion Pharmaceuticals (RXRX). It is a clinical-stage “TechBio” company that uses AI, automation, and large biological datasets to discover and develop new medicines.
Let’s find out if Recursion is a good AI stock to buy now.